MIC3 Gene of Toxoplasma gondii Is a Novel Potent Vaccine Candidate against Toxoplasmosis

Infection and Immunity

Volumn 71, Issue 11, 2003, Pages 6222-6228

  Ismael, Alaa Bassuny ^a   Sekkai, Dalila ^a   Collin, Christine ^a   Bout, Daniel ^a   Mévélec, Marie Noëlle ^a,b  

^a UFR Sci Pharmaceutiques Univ F   (France)

^b CEMAGREF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; DNA VACCINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G2A; INTERLEUKIN 2; PARASITE ANTIGEN; PROTOZOAL PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; BRAIN CYST; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG DESIGN; DRUG EFFICACY; DRUG POTENCY; EVALUATION; FEMALE; HISTOPATHOLOGY; MOUSE; NONHUMAN; PARASITE VIRULENCE; PLASMID; PRIORITY JOURNAL; PROTECTION; PROTEIN FUNCTION; PROTOZOON; TH1 CELL; TOXOPLASMA GONDII; TOXOPLASMOSIS; VACCINATION;

ADHESINS, BACTERIAL; ANIMALS; ANTIBODIES, PROTOZOAN; CARRIER PROTEINS; CYTOKINES; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; IMMUNOGLOBULIN G; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C3H; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL; VACCINATION; VACCINES, DNA;

EID: 0242349654     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.11.6222-6228.2003     Document Type: Article

References (41)

1. Achbarou, A., O. Mercereau-Puijalon, J. M. Authemen, B. Fortier, D. Camus, and J. F. Dubremetz. 1991. Characterization of microneme proteins of Toxoplasma gondii. Mol. Biochem. Parasitol. 47:223-233.
2. Ajzenberg, D., A. L. Banuls, M. Tibayrenc, and M. L. Darde. 2002. Microsatellite analysis of Toxoplasma gondii shows considerable polymorphism structured into two main clonal groups. Int. J. Parasitol. 32:27-38.
3. Ajzenberg, D., N. Conge, L. Paris, M. H. Bessiers, P. Thulliez, D. Filisetti, H. Pelloux, P. Marty, and M. L. Darde. 2002. Genotype of 86 Toxoplasma gondii isolates associated with human congenital toxoplasmosis, and correlation with clinical findings. J. Infect. Dis. 186:684-689.
4. Alarcon, J. B., G. W. Waine, and D. P. McManus. 1999. DNA vaccines: technology and application as anti-parasite and anti-microbial agents. Adv. Parasitol. 42:343-410.
5. Angus, C. W., D. Klivington-Evans, J. P. Dubey, and J. A. Kovacs. 2000. Immunization with a DNA plasmid encoding the SAG1 (P30) protein of Toxoplasma gondii is immunogenic and protective in rodents. J. Infect. Dis. 181:317-324.
6. + T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp 120 and GM-CSF. J. Immunol. 168:562-568.
7. Bout, D. T., M.-N. Mévélec, F. Velge-Roussel, I. Dimier-Poisson, and M. Lebrun. 2002. Prospects for a human Toxoplasma vaccine. Curr. Drug Targets-Immune Endocr. Metab. Dis. 2:227-234.
8. Bowne, W. B., J. D. Wolchok, W. G. Hawkins, R. Srinivasan, P. Gregor, N. E. Blachere, Y. Moroi, M. E. Engelhorn, A. N. Houghton, and J. J. Lewis. 1999. Injection of DNA encoding granulocyte-macrophage colony-stimulating factor recruits dendritic cells for immune adjuvant effects. Cytokines Cell Mol. Ther. 5:217-225.
9. Brown, C. R., A. Hunter, R. G. Estes, E. Beckmann, J. Formann, C. David, J. S. Remington, and R. McLeod. 1995. Definitive identification of a gene that confers resistance against Toxoplasma gondii cyst burden and encephalitis. Immunology 85:419-428.
10. Buxton, D. 1998. Protozoan infections (Toxoplasma gondii, Neospora caninum and Sarcocystis spp.) in sheep and goats: recent advances. Vet. Res. 29:289-310.
11. Buxton, D., K. Thomson, S. Maley, S. Wright, and H. J. Bos. 1991. Vaccination of sheep with a live incomplete strain (S48) of Toxoplasma gondii and their immunity to challenge when pregnant. Vet. Rec. 129:89-93.
12. Cérède, O., J. F. Dubremetz, D. Bout, and M. Lebrun. 2002. The Toxoplasma gondii protein MIC3 requires pro-peptide cleavage and dimerization to function as adhesin. EMBO. J. 2:1-11.
13. Chardès, T., I. Bourguin, M.-N. Mévélec, J. F. Dubremetz, and D. Bout. 1990. Antibody responses to Toxoplasma gondii in sera, intestinal secretions and milk from orally infected mice and characterization of target antigens. Infect. Immun. 58:1240-1246.
14. Chen, G., H. Guo, F. Lu, and H. Zheng. 2001. Construction of a recombinant plasmid harbouring the rhoptry protein 1 gene of Toxoplasma gondii and preliminary observation on DNA immunity. Chin. Med. J. 114:837-840.
15. Davis, H. L., M.-L. Michel, M. Mancini, M. Schleef, and R. G. Whalen. 1994. Direct gene transfer in skeletal muscule: plasmide DNA based immunization against the hepatitis B virus surface antigen. Vaccine 12:1503-1509.
16. Debard, N., D. Buzoni-Gatel, and D. Bout. 1996. Intranasal immunization with SAG1 protein of Toxoplasma gondii in association with cholera toxin dramatically reduces development of cerebral cysts after oral infection. Infect. Immun. 64:2158-2166.
17. Denkers, E. Y., and R. T. Gazzinelli. 1998. Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clin. Microbiol. Rev. 11:569-588.
18. Desolme, B., M.-N. Mévélec, D. Buzoni-Gatel, and D. Bout. 2000. Induction of protective immunity against toxoplasmosis in mice by DNA immunization with a plasmid encoding Toxoplasma gondii GRA4 gene. Vaccine 18:2512-2521.
19. Doolan, D. L., and S. L. Hoffman. 2001. DNA-based vaccines against malaria: status and promise of the Multi-Stage Malaria DNA Vaccine Operation. Int. J. Parasitol. 31:753-762.
20. Drew, D. R., M. Lightowlers, and R. A. Strugnell. 2000. Humoral immune responses to DNA vaccines expressing secreted membrane bound and nonsecreted forms of the Tania ovis 45W antigen. Vaccine 18:2522-2532.
21. Dubey, J. P. 2000. The scientific basis for prevention of Toxoplasma gondii infection: studies on tissue cyst survival, risk factors and hygiene measures, p. 271-275 In P. Ambroise-Thomas and E. Petersen (ed.), Congenital toxoplasmosis: scientific background, clinical management and control. Springer-Verlag, Paris, France.
22. Gagne, S. S. 2001. Toxoplasmosis. Prim. Care Update Ob/Gyn. 8:122-126.
23. Garcia-Réguet, N., M. Lebrun, M. N. Fourmaux, O. Mercereau-Puijalon, T. Mann, C. J. Beckers, B. Samyn, J. Van Beeumen, D. Bout, and J. F. Dubremetz. 2000. The microneme protein MIC3 of Toxoplasma gondii is a secretory adhesin that binds to both the surface of the host cells and the surface of the parasite. Cell Microbiol. 2:353-364.
24. Haddad, D., J. Ramprakash, M. Sedegah, Y. Charoenvit, R. Baumgartner, S. Kumar, S. L. Hoffman, and W. R. Weiss. 2000. Plasmid vaccine expressing granulocyte-macrophage colony-stimulating factor attracts infiltrates including immature dendritic cells into injected muscles. J. Immunol. 165:3772-3781.
25. Jones, T., A. Stern, and R. Lin. 1994. Potential role of granulocyte-macrophage colony-stimulating factor as vaccine adjuvant. Eur. J. Clin. Microbiol. Infect. Dis. 2:47-53.
26. Kamath, A. T., T. Hanke, H. Briscoe, and W. J. Britton. 1999. Co-immunization with DNA vaccines expressing granulocyte-macrophage colony-stimulating factor and mycobacterial secreted proteins enhances T-cell immunity but not protective efficacy against Mycobacterium tuberculosis. Immunology 96:511-516.
27. Kim, J. J., J. S. Yang, D. J. Lee, D. M. Wilson, L. K. Nottingham, L. Morrison, A. Tsai, J. Oh, K. Dang, T. Dentchev, M. G. Agadjanyan, J. I. Sin, A. A. Chalian, and D. B. Weiner. 2000. Macrophage colony-stimulating factor can modulate immune responses and attract dendritic cells in vivo. Hum. Gene Ther. 11:305-321.
28. Kowalczyk, D. W., and H. C. Ertl. 1999. Immune responses to DNA vaccines. Cell Mol. Life Sci. 55:751-770.
29. Leyva, R., P. Herion, and R. Saavedra. 2001. Genetic immunization with plasmide DNA coding for the ROP2 protein of Toxoplasma gondii. Parasitol. Res. 87:70-79.
30. Mendez, S., Y. Belkaid, R. A. Seder, and D. Sacks. 2002. Optimization of DNA vaccination against cutaneous leishmaniasis. Vaccine 20:3702-3708.
31. Montgomery, D. L., J. B. Ulmer, J. J. Donnelly, and M. A. Liu. 1997. DNA vaccines. Pharmacol. Ther. 74:195-207.
32. Nielsen, H.V., S. L. Lauemøller, L. Christiansen, S. Buus, A. Fomsgaard, and E. Petersen. 1999. Complete protection against lethal Toxoplasma gondii infection in mice immunized with a plasmid encoding the SAG1 gene. Infect. Immun. 67:6358-6363.
33. + T cells to control acute Toxoplasma gondii infection. Infect. Immun. 71:309-316.
34. Sharma, S. D., J. Mullenack, F. G. Araujo, H. A. Erlich, and J. S. Remington. 1983. Western blot analysis of the antigens of toxoplasma gondii recognized by human IgM and IgG antibodies. J. Immunol. 131:977-983.
35. Sin, J. I., J. J. Kim, K. E. Ugen, R. B. Ciccarelli, T. J. Higgins, and D. B. Weiner. 1998. Enhancement of protective humoral (Th2) and cell-mediated (Th1) immune responses against herpes simplex virus-2 through co-delivery of granulocyte-macrophage colony-stimulating factor expression casettes. Eur. J. Immunol. 28:3530-3540.
36. Suzuki, Y., M. A. Orellana, S. Y. Wong, F. K. Conley, and J. S. Remington. 1993. Susceptibility to chronic infection with Toxoplasma gondii does not correlate with susceptibility to acute infection in mice. Infect. Immun. 61:2284-2288.
37. Tenter, A. M., A. R. Heckeroth, and L. M. Weiss. 2000. Toxoplasma gondii: from animals to humans. Int. J. Parasitol. 30:1217-1258.
38. Vercammen, M., T. Scorza, K. Huygen, J. De Braekeleer, R. Diet, D. Jacobs, E. Saman, and H. Verschueren. 2000. DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7 and ROP2 induces partially protective immunity against lethal challenge in mice. Infect. Immun. 68:38-45.
39. Warren, T. L., and G. J. Weiner. 2000. Uses of granulocyte-macrophage colony-stimulating factor in vaccine development. Curr. Opin. Hematol. 7:168-173.
40. Weiss, W. R., R. J. Ishii, R. C. Hedstrom, M. Sedegah, M. Ichino, K. Barnhart, D. M. Klinman, and S. L. Hoffman. 1998. A plasmid encoding murine granulocyte-macrophage colony-stimulating factor increases protection conferred by a malaria DNA vaccine. J. Immunol. 161:2325-2332.
41. Xiang, Z. Q., and H. C. J. Ertl. 1995. Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity 2:129-135.